Rua Diagnostics Inc. is a medical technology company developing breath-based diagnostic testing technology using gas chromatography and AI/ML software analysis. The company focuses on investigational diagnostic solutions for detecting conditions such as lung cancer, colorectal cancer, and COVID-19 variants.
Subscribe to see Rua Diagnostics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Rua Diagnostics Inc. is a medical diagnostics company headquartered in United States. Its most recent funding round raised $3.6M in May 2026. Xcout tracks 5 named people at Rua Diagnostics Inc., including Jillian Levovitz (Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Rua Diagnostics Inc.'s closest competitors — see the full list of competitors and alternatives →
Owlstone Inc. is a diagnostics-focused company that works in the field of breath-based testing and breath biopsy diagnostics.
Oxford Cancer Analytics (OXcan) is a medtech and diagnostics company that develops minimally invasive liquid biopsy blood tests for early cancer detection and management. The company utilizes advanced proteomics and machine learning to generate blood-based biomarkers, initially focusing on lung cancer.
Liquid Lung DX, Inc. is a liquid biopsy company developing diagnostic programs aimed at early detection of lung diseases, beginning with lung cancer. Its stated goal is to preserve quality of life by identifying disease at its earliest stages. The homepage describes its programs as under development and invites inquiries through a contact form.
Hera Diagnostics Corp develops non-invasive, AI-powered diagnostic tools and molecular tests for women's health conditions, focusing on endometriosis detection and staging as well as point-of-care cervical cancer screening. The company provides practice-ready diagnostic solutions for OB-GYN, fertility, and clinical care workflows.
IR Medtek LLC develops non-invasive cancer detection technology for early identification of skin and other cancers. The company utilizes light detection, machine learning, and advanced algorithms to improve diagnostic accuracy for healthcare applications.
DELFI Diagnostics is a cancer detection company that utilizes artificial intelligence and whole genome fragmentation analysis to develop blood-based cancer screening tests, such as for lung cancer.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Rua Diagnostics Inc.? Suggest a correction · Work at Rua Diagnostics Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.